Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)

Last updated: January 10, 2026
Sponsor: Bruyère Health Research Institute.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Menstruation

Ovulation

Reproductive Health

Treatment

Premom App-Assisted Fertility Tracking

Clinical Study ID

NCT07248046
REB-2026-56
  • Ages 16-45
  • Female
  • Accepts Healthy Volunteers

Study Summary

This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone [LH], pregnanediol glucuronide [PDG], and basal body temperature [BBT]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, perform urine tests, upload test strip photos to the Premom App, and measure BBT. Both participant readings and AI-assisted app readings will be analyzed. The main goal is to find which marker pairings give the most accurate picture of ovulation timing and luteal phase length. Secondary goals include understanding ease of use, the number of tests required, and whether the app improves accuracy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female, aged 16 to 45

  • Natural menstrual cycles equal or less than 35 days

  • Off hormonal contraception for more than 3 months

  • Current user of the Premom App

  • Willing to track cervical mucus, LH, PDG, and BBT for 3 full cycles

  • Lives within 50 km of study site in the Ottawa region

  • Able to provide informed consent

Exclusion

Exclusion Criteria:

  • Pregnant or breastfeeding

  • Current hormonal therapy or contraception

  • Known anovulatory disorders, e.g., Polycystic Ovary Syndrome, hypothalamicamenorrhea.

  • Very irregular or absent cycles

  • Not using the Premom App

  • Unable or unwilling to complete tracking or provide consent

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Premom App-Assisted Fertility Tracking
Phase:
Study Start date:
January 15, 2026
Estimated Completion Date:
November 15, 2026

Study Description

This study examines how well different combinations of fertility signs-cervical mucus changes, hormone levels in urine, and body temperature-can help identify ovulation and luteal phase length. The study uses the Premom App, which allows users to record fertility signs and take photos of urine hormone test strips for AI-assisted interpretation. Four marker pairs will be compared: Mucus plus PDG, LH plus PDG, Mucus plus BBT, and LH plus BBT. Each participant will track three cycles, with both app-based and user-based readings analyzed. The study will assess which marker pairings are most accurate and user-friendly. Secondary endpoints include usability, test burden, and app vs. participant agreement. Results may support improvements in fertility awareness and digital health tools. Risks are minimal and involve time commitment for daily tracking. This is an observational study. Participants are not assigned to any intervention; all fertility signs collected are part of their existing self-tracking using the Premom App. The study analyzes these naturally occurring data to compare marker pairings for identifying ovulation and luteal phase length.

Connect with a study center

  • St. Laurent Ideal Clinic

    Ottawa 6094817, Ontario 6093943 K1G 3V4
    Canada

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.